(Q45151652)

10 December 2017

title

Sirolimus interacts with pathways essential for podocyte integrity (English)

1 reference

10 December 2017

1 reference

2

Patrick Bruneval

1 reference

10 December 2017

Emmanuel Letavernier

1

1 reference

10 December 2017

Sophie Vandermeersch

3

1 reference

10 December 2017

Joelle Perez

4

1 reference

10 December 2017

Chantal Mandet

5

1 reference

10 December 2017

Marie-France Belair

6

1 reference

10 December 2017

Jean-philippe Haymann

7

1 reference

10 December 2017

Christophe Legendre

8

1 reference

10 December 2017

Laurent Baud

9

1 reference

10 December 2017

language of work or name

English

0 references

publication date

16 October 2008

1 reference

Nephrology Dialysis Transplantation

10 December 2017

published in

1 reference

10 December 2017

volume

24

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

630-638

1 reference

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

VEGF-C promotes survival in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

21 January 2018

The complex life of WT1

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

Antileukemic activity of rapamycin in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN574

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN574

1 reference

10 December 2017

1 reference